Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rxo (RXO) Acquisitions (2024 - 2025)

Historic Acquisitions for Rxo (RXO) over the last 2 years, with Q1 2025 value amounting to $10.0 million.

  • Rxo's Acquisitions changed N/A to $10.0 million in Q1 2025 from the same period last year, while for Dec 2025 it was $10.0 million, marking a year-over-year decrease of 9901.86%. This contributed to the annual value of $10.0 million for FY2025, which is 9901.86% down from last year.
  • Rxo's Acquisitions amounted to $10.0 million in Q1 2025.
  • In the past 5 years, Rxo's Acquisitions ranged from a high of $1.0 billion in Q3 2024 and a low of $10.0 million during Q1 2025